Doctor in Chemistry (Institut Químic de Sarrià, 2001) and MBA (UB, 2007)
Josep Lluís has 20 years’ experience in the biomedical sector. He has worked for big pharma companies (Sanofi), mid-size pharmas (Ferrer Grupo), small biotechs (Hospital spin-off), tech transfer offices (Fundació Bosch i Gimpera) and consulting firms (Antares Consulting and Asphalion). He has also been associate professor at IQS.
His experience is based on healthcare strategy, technology transfer, fundraising of start-up companies, business development, marketing, market access, reimbursement and regulatory affairs.
Josep Lluís has founded four companies. He currently serves as board member for three start-up companies and he is mentor of several entrepreneurs. In addition, in the last four years he has been involved in six private fundraising processes and he has contributed to raising more than 60 million euros for his clients.
The projects Josep Lluís has been involved in are based on small chemical entities, biologicals, diverse medical devices, in vitro diagnostics, nutraceuticals and cosmetics. The therapeutic areas where he has recently worked are oncology, the central nervous system, cardiovascular, ophthalmology, orthopaedics, traumatology, HIV, microbiome, antibacterials and immunomodulation. He has a complete knowledge of drug/device development, having worked in the discovery, preclinical and clinical phases, as well as marketing and post-marketing.
He takes part in programmes such as Caixa Impulse and EIT Health programmes, participating as reviewer, mentor and professor.
The entrepreneurial spirit runs through his veins. He has founded GENESIS Biomed to help other entrepreneurs and research centre in their current projects.
PhD in Chemistry, Master in Project Management, PMP®.
PhD in Chemistry, Master’s degree in Project Management, PMP® Natalia has worked in the academic sphere (CSIC Madrid and Barcelona) and in the pharmaceutical industry: big pharma (Fresenius Kabi, Sanofi, Lilly, Merck-Serono), mid-size (Almirall, Palau Pharma) and start-ups (Ojer Pharma, ImmunNovative Developments, Enantia).
She has worked in different positions in areas as project management, regulatory affairs, R&D and quality, among others.
The main therapeutic areas she has been involved in are oncology, the central nervous system, anti-inflammatories, antibacterials, autoimmune diseases and cardiovascular.
Since 2015 she has focused mainly on project management, broadening her knowledge of economic and administrative monitoring and control, requesting changes and the dissemination of project results.
During her last job at the FSJD (Fundació Sant Joan de Déu) she was involved in publicly funded projects, some of them collaboratives, allowing her to work in another health environment.
She joins GENESIS Biomed in April 2019. She is passionate about improving the quality of life and health for patients.
Jordi Ortiz. MSc in Chemistry, Biochemistry field (Universitat de Barcelona, UB). Higher Education in Quality Management, ISO 9001 (Universitat Oberta de Catalunya, UOC).
He completed his Master Thesis in Cation-induced aggregation and fusion of N-acyl-N-methylphosphatidyl-ethanolamine liposomes and continued his research by studying the lipid-protein interaction. In 2021 he finished his advanced course in quality management at UOC.
In 1994, he joined the pharmaceutical industry and has occupied several positions, always in the R&D area (from Discovery to Clinical phases). He has worked in Sanofi, Ferrer and Spherium Biomed. In this last company he has hold the position of Senior Project Manager working in several projects from the discovery phase until the clinical research phase.
He has an extended experience in several management positions in regulated analysis laboratories and as project manager with both large and small molecules.
During the last years, he has been working in Autoinmune Diseases, Muscle recovery, ALS, Oncology Mucositis and Acute Kidney Injury.
Jordi has also a deep expertise in European public fundraising and in Business Development activities, all of them related to the projects in which he has participated.
He joins GENESIS Biomed in March 2019. He is a passionate of biomedical innovations of academic origin in order to accelerate their transition to the market. Customer focus, Leadership, People engagement, Process-based approach, Improvement, Evidence-based decision making, and Relationship management are his main drivers.
Joan Carles Fernàndez. Doctor in pharmacy, with a PhD in organic chemistry, MSc in chemistry, and a BSc in pharmacy, on the analytical/clinical side, (Universitat de Barcelona). He has done postdoctoral work in organic chemistry (Exeter University, UK) and in medicinal chemistry (Institute of Cancer Research, London, UK).
Joan Carles has over 18 years’ experience as a medicinal chemist at Parc Científic de Barcelona (PCB) providing research services for Almirall and Esteve pharmaceuticals, working on different projects within the following areas: oncology, respiratory (asthma, COPD), chronic and neuropathic pain among others. He also has experience in combinatorial chemistry and the preparation of corporate libraries for HTS campaigns (Almirall-PCB unit, and Evotec OAI, Oxford, UK).
After all these years in drug discovery, he has become an experienced senior leader with a proven track record of supporting successful drug discovery programmes, developing teams and successful people, and gaining extensive experience in dealing with several decision-making groups of computational chemists, biologists and pharmacologists. This process has professionally transformed him into an interdisciplinary scientist.
Furthermore, he has a broad background experience and formation in hospital pharmacy and analytical laboratories: haematology, biochemistry, hormonal, microbiology (Hospital de Sant Joan de Déu). He is an energetic team player who cooperates well with co-workers and colleagues and strives for success.
Joan Carles joined GENESIS Biomed in July 2020, with his passion for research in biomedical science and the drug discovery process. His main aim as a scientific consultant is to provide support and help to startups, entrepreneurs, biotechnology-related institutions, foundations and companies to develop innovative solutions in health for all.
Jaume Ruiz MSc in Pharmacy ( International MBA (La Salle, URL), Master in Project Management (La Salle, URL), Pharmacist Specialist in Industrial and Galenical Pharmacy and Pharmacist Specialist in Analysis and Control of Drug Products and Substances.
During 25 years he joined the pharmaceutical industry and occupied several positions, always in the Pharmaceutical Development R&D area (including preformulation formulation, scale up, launching and Clinical Trials Supplies from
Phase I to IV) He has worked in Almirall Procter Gamble Pharmaceuticals (USA and Spain), Vita and Salvat In this last company he hold the position of Head of Pharmaceutical Development R&D He has extended experience in GMP, ICH guidelines (EMA FDA), and a PAI of the FDA (for Almotriptan Project), and holds two patents He was the responsible for Ebastel Cidine Cetraxal Relive, etc development, scale up and launch.
During the past 8 years, he has been working in Innovation, Tech Transfer, Business Development, creation of Spin off and Licensing areas at IDIBELL, VHIR and IGTP In this last Institute, reporting to the General Director and participating
in different Strategic Committees, he has hold the positions of Head of Innovation and Business Development, and Head of Quality, maintaining the Strategic Plan, the ISCIII and CERCA accreditations, KPI and the SGDQ, keeping everything updated In addition, he served as a senior consultant in Colombia, implementing Innovation Units in 5 of the largest hospitals in LATAM.
Jaume is co author of the book “¿Innovas o Trabajas De la Idea al Paciente and has spent more than 25 years as professor of several masters ( UAB, URL, IUCT) on biomedical research management, innovation and business.
He joined GENESIS Biomed in February 2021 He is a passionate of consulting, accreditations, health innovations, quality, corporate training, change management, balanced scorecard, team mentoring and strategic plans for organizations.
BSc in Biology (Universitat de Barcelona, 2013) and Master in Genetics and Genomics (Universitat de Barcelona, 2014).
Mireia has more than 4 years of experience in the research industry, as she started her professional career in IDIBELL (Institut d’Investigació Biomèdica de Bellvitge), Hospital Clínic and IBEC (Institut de Bioenginyeria de Catalunya).
In IBEC, Mireia worked for three years as research assistant in various stem cell projects in the field of heart and kidney differentiation and regeneration.
She joined GENESIS Biomed in June 2018. During these years, she has worked in several projects in the areas of oncology, infectious diseases and ophthalmology, among others.
Since her incorporation she has gained a vast experience in Business Plan preparations, market analysis, regulatory and development plans, financial and strategic plans, private fundraising and technology transfer.
Mireia has also a deep expertise in European Projects in which she has been involved during this years at GENESIS Biomed.
She is an enthusiast of biomedical sciences and delighted to help them to accelerate their entrance to the market.
BSc in Biotechnology (Universitat de Barcelona, 2019 and MSc in Management of Biotech companies from CESIF.
Mariona studied Biotechnology and took a Master’s degree in Management of Biotech companies at CESIF in order to assist the establishment and growth of small biotechnological companies She carried out her final degree project with the spin-off DBGen Ocular Genomics, where she performed tasks related to the optimisation of the diagnosis of inherited retinal disorders.
She joined GENESIS Biomed in January. Mariona is passionate about life sciences and looks forward to supporting the creation of spin-offs and start-ups.
BSc in Biotechnology (Universitat de Barcelona, 2019) and MSc in Technology and Management of Biotech companies (CESIF 2020).
Alberto has experience as an undergraduate researcher in laboratories belonging to the University of Cologne. He developed his Bachelor’s dissertation at CECAD studying ubiquitin and its effect on cell regulation and homeostasis under stress conditions, under the supervision of Dr Mafalda Escobar Henriques Dias. Eager to acquire and develop his career in biotech-based company management he completed a Master’s degree at CESIF in Technology and Management of such companies.
Alberto joins GENESIS Biomed in January 2020. With his scientific background he looks forward to help in the development of spin-off and start-up companies, considering technology transfer as a tool of innovation.
Bsc in Biotechnology (Universitat de Vic, 2020) and Master in Management of Biotech companies at CESIF.
Berta studied Biotechnology and took a Master’s Degree in Management of Biotech companies at CESIF. During her studies, she acquired knowledge and experience in the field of research, working in the Chemistry Department at UAB, in the Neurosciences research area at VHIR or in the Belgian National Institute of Public Health, Sciensano.
In her master’s degree, she discovered another biotechnology field, and now she is ready to take a step further. Therefore, Berta joins GENESIS Biomed in January 2021, with the aim to learn and help startups/spinoffs or research centers to obtain innovative results.
BSc in Biology (UB – Universitat de Barcelona, 2020) and Master in Management of Biotech companies at CESIF.
Marc studied Biology at UB and did a Master in Management of Biotech companies at CESIF to improve his learning on the structure, function and management of the Biotech companies. He developed his finally degree project in a research group of cancer about the metabolism of colon cancer.
Marc joined GENESIS Biomed in January 2021. He is ready to use his skills to help with the creation and development of start-up and spin-off companies.
BSc in Biotechnology (IQS – Universitat Ramon Llull, 2020) and Master in Management of Biotech companies at CESIF.
Biotechnologist with experience in the laboratory and interested in knowing and developing myself in the bio-business world. After doing an internship trainee at CiMUS (Center for Research in Molecular Medicine and Chronic Diseases) based on the reprogramming of macrophages associated with tumors to antitumor macrophages, she realized that her profile could enhance communication between science and the business world. For this reason, she cursed a master’s in Technology and Management of Biotech companies at CESIF.
Mariona joins GENESIS Biomed in February 2021 with the aim that the connection of science and business can lead to innovative results.
Currently cursing a Bachelor in economics (UB-University of Barcelona).
4th year student of Economics in the University of Barcelona with a high scope in health economy. After a few courses about the particularity of health, she found out that economy is an incredible tool that can help in the organization and use of scarce resources in the best and efficient way. Now, she would like to take the challenge to put in practice the economic theory and to expand her knowledge about business around health.
Athena joins GENESIS Biomed in October 2021 with the purpose of contributing to the development of the entrepreneurial projects running at the company.
BSc in Biology (UAM- Universidad Autónoma de Madrid, 2021) and currently attending the MSc in Management of Biotech companies at CESIF.
Biologist with experience in both laboratory and research assistance. He completed his last degree year, including his Bachelor´s Degree Project, in Stockholm University. The project was about Toxoplasma gondii infection and consequences in human nervous system.
Alonso joins GENESIS Biomed in March 2022. Eager to develop business skills to combine them with his scientific knowledge in a company.
BSc in Biology (UB – Universitat de Barcelona, 2021) and currently attending the MSc in Management of Biotech companies at CESIF.
Biologist with experience in both research and quality control laboratory. She has developed her final degree project within a research group to study the neurogenerative capacity after a medullar lesion in tadpoles. Eager to learn all about the bio-business world to help new companies to achieve their goals.
Marta joins GENESIS Biomed in March 2022. Eager to learn all about the bio-business world to help new companies to achieve their goals.